Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.
Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...
Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...
Oppenheimer lowered the firm’s price target on Cigna (CI) to $375 from $400 and keeps an Outperform rating on the shares. The firm notes ...
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...
Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.
Q4 2024 Management View CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback